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Previewsresponse due, at least in part, to
increased Erk1/2 signaling. Previous
reports have shown that Fgf signaling
promotes proliferation of embryonic car-
diomyocytes and Erk1/2 acts down-
streamof Fgf signaling in this process (En-
gel et al., 2006). Kubin et al. (2011) show
that combined treatment of cardiomyo-
cytes with Fgf2 and OCM increased entry
into S-phase more efficiently than treat-
ment with individual factors. Thus, in
response to OCM treatment, cardiomyo-
cytes do dedifferentiate and try to prolif-
erate. As yet unknown blocks to cell cycle
re-entry are still present, however, pre-
venting a robust proliferative response to
OCM.
Pathways that regulate the dedifferenti-
ated state of cardiomyocytes are clearly
important and may eventually lead to
methods to promote cardiomyocyte re-
placement after injury in the human heart.
The major roadblock to such an approach
still appears to be the inability of cardio-
myocytes to fully re-enter the cell cycle.
Although increased cardiomyocyte cell
division after treatment with neuregulin or388 Cell Stem Cell 9, November 4, 2011 ª20ErbB4 has been reported, the overall effect
is still rather low (i.e., approximately 0.6%
of cardiomyocytes in vivo responded to
these treatments) (Bersell et al., 2009).
Cardiomyocytes need to maintain proper
contractile function or the biomechanics
of the heart will fail. Although lower verte-
brate cardiomyocytes do go through a
process of dedifferentiation, proliferation,
and redifferentiation to repair injury, the
high cardiac output in mammalian hearts
may preclude such a mechanism as it
could lead to a lethal drop in cardiac out-
put because of decreased contractility.
The finding that OCM promotes dedif-
ferentiation, however, may help lead to
approaches that could promote dediffer-
entiation and ultimately increase cardio-
myocyte replacement after injury-induced
loss in humans.ACKNOWLEDGMENTS
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How DNA methyltransferases, with their limited target specificity, establish cell-type-specific epigenetic
patterns is poorly understood. Schu¨beler and colleagues (Lienert et al., 2011) now show that methylation-
determining regions (MDRs) within promoter regions are sufficient to recapitulate endogenous patterns
and dynamics of DNA methylation.DNA methylation of CpG dinucleotides is
required for normal mammalian develop-
ment. Most of the genome contains few
CpGs and they tend to be methylated
across all cell types. Unmethylated
CpGs are typically found in clusters called
CpG islands (CGIs), which comprise
about 1%–2% of the genome. About half
of CGIs in mouse and human are associ-
ated with transcription start sites (Deatonand Bird, 2011), and many are linked to
housekeeping genes and developmental
regulators. While the enzymes respon-
sible for establishing and maintaining
DNA methylation have been well-studied
and genome-scale data sets continue
to shed light on its genomic distribution
(Meissner, 2010), it remains less clear
how particular sites in the genome are
protected and others are targeted formaintenance or de novo methylation.
None of the three catalytically active DNA
methyltransferases (Dnmt1, 3a, and 3b)
shows a particular target preference that
could explain cell-type-specific methyla-
tion patterns, suggesting that alternative
mechanisms must be in place to either
direct or inhibit their recruitment.
In a recent issue of Nature Genetics,
Schu¨beler andcolleaguessetout to further
Figure 1. Methylation-Determining Regions Guide Methylation
Insertion of promoter DNA sequences into inert genomic regions recapitulates
endogenous DNAmethylation patterns as long as the methylation-determining
region (MDR) is included. Lienert et al. show that the presence of TF binding
motifs combined with a higher CG density provides protection from methyla-
tion. A high-chromatin CG density is also associated with recruitment of
both activating (H3K4 methylation) and repressive (H3K27 methylation) marks.
TF binding motifs and factors shift the balance toward activating marks, which
are inversely correlated with DNAmethylation, whereas absence of TF binding
leads to PRC2 recruitment and H3K27 methylation.
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Previewsinvestigate the role of the
underlying genome sequence
in guiding DNA methylation
(Lienert et al., 2011). The
authors utilized an elegant
and effective recombinase-
mediated cassette exchange
(RMCE) strategy, which was
targeted to the inert environ-
ment of the b-globin locus in
mouse embryonic stem cells
(mESCs). The authors could
thus compare methylation
patterns of dozens of different
sequences under identical
and controlled conditions,
independent of transcriptional
control. Notably, a 1013 bp
fragment of the proximal
Nanog promoter lacking its
upstream enhancer region
was sufficient to recapitulate
the characteristic unmethy-
lated pattern in mESCs and
direct de novo methylation inmESC-derived neural progenitor cells
(NPCs). No recruitment of the transcrip-
tional apparatus to the insertwasdetected,
but nonetheless enrichment of H3K4me2
was seen in the unmethylated mESC
context. To generalize the findings beyond
the Nanog promoter, Lienert et al. inserted
nine additional promoter sequences and
found that all of them recapitulated their
endogenous promoter methylation status.
Similar to the Nanog promoter insert, the
tested promoters also recapitulated their
endogenous H3K4 methylation pattern
within a cell-type-specific context and
without detectable transcription or PolII
recruitment.
Zooming further into the relevant
sequence features, the authors designed
23 truncations to screen for minimal
elements that could confer control over
the expected DNA methylation pattern.
Interestingly, many of these failed, with
a rough functional cutoff around 700 bp
of necessary sequence, leading the
authors to examine whether it is simply
the length of the fragments or specific
sequences within them that can confer
the observed controlling effect. The
Gtf2a1l locus provided an example in
favor of the latter hypothesis, because
a 176 bp fragment of the promoter was
sufficient to establish correct patterning.
The authors termed these smaller regions
methylation-determining regions (MDRs)(Figure 1). However, examination of all
fragments revealed a striking correlation
between CpG density and hypomethyla-
tion. To distinguish between the effect of
CpG density alone and transcription
factor (TF) binding sites as the regulatory
core, Lienert et al. inserted ectopic, non-
regulatory E. coli sequences at CpG
densities that correspond to those of
unmethylated mouse promoters (Lienert
et al., 2011). Interestingly, 7 out of 10
fragments became methylated with par-
tial protection observed exclusively in
the highest density fragments. Previous
work also using integrated E. coli regions
of CGI-like density showed that they are
sufficient to recruit polycomb complex
PRC2, leading to H3K27me3 in the ab-
sence of activating motifs and binding
factors (Mendenhall et al., 2010). A third
study by Bird and colleagues showed
that integration of an artificial CGI-like
sequence recruits Cfp1 and results in
gain of H3K4me3 at the inserts (Deaton
and Bird, 2011). Taken together, the
results from all three groups suggest that
CpG-rich sequences devoid of TF binding
sites and factors are susceptible to DNA
methylation but that this susceptibility
gradually decreases with higher CpG
density and, possibly, recruitment of
alternate epigenetic modifiers such as
H3K4 methyltransferases or polycomb
group proteins.Cell Stem Cell 9, November 4,To further investigate the
role of DNA binding motifs,
the authors mutated 4 bp
sequences within the minimal
Gtf2a1l fragment, excluding
CpG sites to control for CpG
density. Loss of any site in-
creased DNA methylation
levels,whereasacombination
of mutations affecting the
SP1, CTCF, and Rfx binding
sites increased levels in an
additive manner. These
experiments showed that
Rfx2 binds the Gtf2a1l MDR
in ESCs and that this binding
is strongly reduced if the
site is mutated, suggesting
that the unmethylated status
of the Gtf2a1l MDR depends
upon cis-regulatory motifs
and their corresponding
factors. As before, this effect
is independent of transcrip-
tion. One may speculate thatloss of Rfx2 as an alternative to mutating
the binding site would have a similar
effect. In line with this, the authors note
that differentiation-induced de novo
methylation of the Gtf2a1lMDR coincides
with transcriptional downregulation of
Rfx2.
Finally, to test whether gain of methyl-
ation is also correctly recapitulated, Lie-
nert et al. took advantage of their NPC
differentiation system. All three fragments
that were tested in thismanner showed de
novo methylation in progenitors, which is
similar to that of their endogenous coun-
terparts. This suggests that MDRs in this
context require no additional sequence
information for differentiation-induced de
novomethylation. However, it still remains
to be seen whether MDRs are actively
recruiting Dnmts or whether it is the
absence of DNA binding factors during
differentiation that results in reduction of
H3K4 methylation and consequent DNA
methylation. In this context, the authors
observed a comparative dominance
between MDRs that direct maintained
hypomethylation and those that are
methylated, which seems more consis-
tent with H3K4-methylation-mediated
protection rather than active recruitment
of de novo methylation. However, certain
enhancer elements such as the proximal
enhancer of the Oct4 promoter have
been previously shown to function as2011 ª2011 Elsevier Inc. 389
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Previewsnucleation sites for de novo methylation
(Athanasiadou et al., 2010).
The results bySchu¨beler andcolleagues
provide important insights into how the
underlying genome sequence guides cell-
type-specific DNA methylation patterns.
However, establishment of histone meth-
ylation patterns is also regulated by the
genome sequence and TF binding and
activity, making it difficult to draw clear-
cut conclusions about specific casual rela-
tionships. DNA methylation patterns and
H3K4 methylation patterns are strongly
anticorrelated (Meissner et al., 2008;
Weber et al., 2007). Moreover, these two
epigenetic modifications are regulated by
inverse requirements for unmethylated
cytosinesbyCfp1within theSetd1methyl-
transferase complex (Deaton and Bird,
2011) and for unmodified H3K4 residues
in nucleosomes during Dnmt3l-mediated390 Cell Stem Cell 9, November 4, 2011 ª20recruitment of Dnmt3a (Ooi et al., 2007).
Chromatin regulators generally appear to
lack sequence-directed target specificity,
and as a consequence are also likely re-
cruited to specific loci by the genomic
context and DNA binding factors. Inte-
grating the relationship between cis-regu-
latory elements and DNA methylation
described by Lienert et al. into the larger
context of other epigenetic modifiers
should provide new and exciting rules for
how these signatures dictate cell-type
specific regulation.REFERENCES
Athanasiadou, R., de Sousa, D., Myant, K., Merusi,
C., Stancheva, I., and Bird, A. (2010). PLoS ONE 5,
e9937.
Deaton, A.M., and Bird, A. (2011). Genes Dev. 25,
1010–1022.11 Elsevier Inc.Lienert, F., Wirbelauer, C., Som, I., Dean, A.,
Mohn, F., and Schubeler, D. (2011). Nat. Genet.,
in press. Published online October 2, 2011. 10.
1038/ng.946.Meissner, A. (2010). Nat. Biotechnol. 28, 1079–
1088.Meissner, A., Mikkelsen, T.S., Gu, H., Wernig, M.,
Hanna, J., Sivachenko, A., Zhang, X., Bernstein,
B.E., Nusbaum, C., Jaffe, D.B., et al. (2008). Nature
454, 766–770.
Mendenhall, E.M., Koche, R.P., Truong, T., Zhou,
V.W., Issac, B., Chi, A.S., Ku, M., and Bernstein,
B.E. (2010). PLoS Genet. 6, e1001244.
Ooi, S.K., Qiu, C., Bernstein, E., Li, K., Jia, D.,
Yang, Z., Erdjument-Bromage, H., Tempst, P.,
Lin, S.P., Allis, C.D., et al. (2007). Nature 448,
714–717.
Weber, M., Hellmann, I., Stadler, M.B., Ramos, L.,
Pa¨a¨bo, S., Rebhan, M., and Schu¨beler, D. (2007).
Nat. Genet. 39, 457–466.You Can Count on This:
Barcoded Hematopoietic Stem CellsHanno Glimm,1,* Claudia R. Ball,1 and Christof von Kalle1,*
1Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ),
69120 Heidelberg, Germany
*Correspondence: hanno.glimm@nct-heidelberg.de (H.G.), christof.kalle@nct-heidelberg.de (C.v.K.)
DOI 10.1016/j.stem.2011.10.013
Understanding how individual hematopoietic stem cells contribute to blood formation requires analysis at the
single-cell level. Recently in Nature Biotechnology, Lu et al. (2011) tagged HSCs with unique molecular barc-
odes and used high-throughput sequencing to track their progeny after transplantation.The stem cell hierarchy of high-turnover
tissues of the adult is rather complex.
Blood formation, one of the most active
and certainly the best characterized stem
cell system in the adult, includes multiple
layers of stem and progenitor cells. Our
knowledge on the in vivo biology of dif-
ferent classes within the hematopoietic
stem cell (HSC) tree has largely been
gained from FACS and subsequent trans-
plantation into syngeneic recipient mice
(Dykstra et al., 2007; Weissman and Shi-
zuru, 2008). True quantification of how
specific subpopulations contribute to
blood formation has, however, proven
difficult. Suitable phenotypic markers arenot available for all functionally defined
stem and progenitor cell types. Associa-
tion of a marker profile to a cell’s function-
ality may not be inherently fixed under all
in vivo conditions, and even less so after
extensive in vitro manipulation or intro-
duction of genetic modifications. Limiting
dilution analysis, the most commonly
used assay to quantify HSC content,
allows the quantification of stem cells
without restriction to a certain phenotype
but is biased toward larger and more
frequent stem cell clones. In vivo ap-
proaches to detect functional HSC output
can also not account for the fact that mul-
tiple stem or progenitor cells make simul-taneous contributions to the observed
blood cell output. In a recent article pub-
lished in Nature Biotechnology, Irving
Weissman and colleagues use a new
methodology to smartly track individual
HSC’ contributions to overall blood forma-
tion (Lu et al., 2011). By introducing a
distinguishable 27 bp variable DNA bar-
code sequence within a lentiviral vector
into individual stem and progenitor cells
before transplantation, posttransplanta-
tion hematopoiesis in their animals carries
a clonal barcode marker in each cell’s
blood cell output. This refinement of a
novel technique allows them to catch
a first glimpse of the clonal repertoire
